Details for New Drug Application (NDA): 021228
✉ Email this page to a colleague
The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 021228
Tradename: | DETROL LA |
Applicant: | Upjohn |
Ingredient: | tolterodine tartrate |
Patents: | 0 |
Pharmacology for NDA: 021228
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for 021228
Suppliers and Packaging for NDA: 021228
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228 | NDA | Pharmacia and Upjohn Company LLC | 0009-5190 | 0009-5190-01 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01) |
DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228 | NDA | Pharmacia and Upjohn Company LLC | 0009-5190 | 0009-5190-02 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 2MG | ||||
Approval Date: | Dec 22, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 4MG | ||||
Approval Date: | Dec 22, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021228
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription